Latest EVH reports update at 2023-11-02: 2023-Q32022-Q3
Evolent Health logo
Evolent Health EVH
$ 32.44 0.0%

Evolent Health Balance Sheet 2011-2024 | EVH

Annual Balance Sheet Evolent Health

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

232 M -43.5 M -90.9 M 194 M -6.46 M -117 M 30.1 M -146 M - -67.9 M - -

Long Term Debt

413 M 216 M 263 M 294 M 221 M 121 M 120 M - - - - -

Long Term Debt Current

7.12 M 7.07 M 7.36 M 6.27 M - - - - - - - -

Total Non Current Liabilities

- - - 376 M 264 M 134 M 156 M 21.4 M 40.3 M 41.6 M - -

Total Current Liabilities

433 M 445 M 402 M 193 M 269 M 133 M 132 M 59.5 M - - - -

Total Liabilities

958 M 726 M 751 M 569 M 533 M 266 M 288 M 80.9 M 40.3 M 70.9 M - -

Deferred Revenue

5.76 M 11.9 M 14.3 M 19.8 M 20.6 M 24.8 M 20.5 M 14.8 M - 16.4 M - -

Retained Earnings

-606 M -627 M -589 M -252 M 50 M 86 M 147 M 307 M -25.8 M - - -

Total Assets

1.82 B 1.42 B 1.37 B 1.5 B 1.72 B 1.31 B 1.2 B 1.02 B 38.3 M 102 M - -

Cash and Cash Equivalents

188 M 266 M 362 M 101 M 228 M 238 M 135 M 146 M - - - -

Book Value

859 M 694 M 620 M 929 M 1.19 B 1.05 B 912 M 935 M -2.07 M 31 M - -

Total Shareholders Equity

859 M 694 M 620 M 922 M 1.14 B 1.01 B 703 M 649 M -2.07 M 13.3 M - -

All numbers in USD currency

Quarterly Balance Sheet Evolent Health

2023-Q3 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

600 M - 412 M - 283 M 216 M 211 M 207 M 202 M 263 M 263 M 263 M 297 M 294 M 228 M 294 M 294 M 221 M 221 M 221 M 221 M 121 M 121 M 121 M 121 M 120 M 120 M 120 M 120 M - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

1.4 B - 903 M - 728 M 726 M 646 M 679 M 688 M 752 M 752 M 752 M 604 M 569 M 569 M 569 M 569 M 533 M 533 M 533 M 533 M 266 M 266 M 266 M 266 M 288 M 288 M 288 M 288 M 80.9 M 80.9 M 80.9 M 80.9 M - 1.07 M 1.07 M - - - - - - - - - - - - -

Deferred Revenue

5.76 M - 7.52 M - 13.3 M 11.9 M 13.8 M 13.2 M 13.4 M 10.2 M 10.2 M 10.2 M 17 M 19.8 M 19.8 M 19.8 M 19.8 M 20.6 M 20.6 M 20.6 M 33.3 M 24.8 M 26.1 M 27.8 M 25.5 M 20.5 M 20.5 M 20.5 M 20.5 M 14.8 M 14.8 M 14.8 M 14.8 M - - - - - - - - - - - - - - - -

Retained Earnings

-686 M - -595 M - -592 M -627 M -621 M -608 M -599 M -589 M -589 M -589 M -334 M -252 M -252 M -252 M -252 M 50 M 50 M 50 M 50 M 86 M 86 M 86 M 86 M 147 M 147 M 147 M 147 M 307 M 307 M 307 M 307 M -25.8 M -25.8 M -25.8 M - - - - - - - - - - - - -

Total Assets

2.67 B - 1.76 B - 1.34 B 1.42 B 1.25 B 1.29 B 1.31 B 1.37 B 1.37 B 1.37 B 1.45 B 1.5 B 1.5 B 1.5 B 1.5 B 1.72 B 1.72 B 1.72 B 1.72 B 1.31 B 1.31 B 1.31 B 1.31 B 1.2 B 1.2 B 1.2 B 1.2 B 1.02 B 1.02 B 1.02 B 1.02 B 37.2 M 38.3 M 38.3 M - - - - - - - - - - - - -

Cash and Cash Equivalents

185 M - 157 M - 210 M 266 M 282 M 207 M 236 M 319 M 319 M 319 M 67.9 M 101 M 101 M 101 M 101 M 228 M 228 M 228 M 228 M 238 M 238 M 238 M 238 M 135 M 135 M 135 M 135 M 146 M 146 M 146 M 146 M - - - - - - - - 5.25 M - - - - - - -

Book Value

1.27 B - 856 M - 611 M 694 M 607 M 614 M 617 M 620 M 620 M 620 M 847 M 929 M 929 M 929 M 929 M 1.19 B 1.19 B 1.19 B 1.19 B 1.05 B 1.05 B 1.05 B 1.05 B 912 M 912 M 912 M 912 M 935 M 935 M 935 M 935 M 37.2 M 37.2 M 37.2 M - - - - - - - - - - - - -

Total Shareholders Equity

1.1 B - 856 M - 611 M 694 M 607 M 614 M 617 M 620 M 620 M 620 M 847 M 922 M 922 M 922 M 922 M 1.14 B 1.14 B 1.14 B 1.14 B 1.01 B 1.01 B 1.01 B 1.01 B 703 M 703 M 703 M 703 M 649 M 649 M 649 M 649 M -2.07 M -2.07 M -2.07 M - 13.3 M - - - 5.2 M - - - - - - -

All numbers in USD currency